1-20 of 28
Thierry de Revel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome:the SFGM-TC Experience

Laura Bounaix, Stephanie Nguyen, MD PhD, Didier Blaise, David Michonneau, MD, Jean-Henri Bourhis, Johan Maertens, Xavier Poire, MD, Patrice Chevallier, MD, Natacha Maillard, MD, Ibrahim Yakoub-Agha, MD PhD, Lionel Mannone, MD, Marc Bernard, MD, Thierry de Revel, MD PhD, Helene Labussiere-Wallet, MD, Patrice Ceballos, MD, Richard Lemal, MD, Eric Hermet, MD, Aurélie Ravinet, MD, Olivier Tournilhac, MD PhD, Jacques-Olivier Bay, MD PhD, Romain Guieze, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3457.
https://doi.org/10.1182/blood-2018-99-117904
Published: 2018
Journal Articles

Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03)

Xavier Leleu, MD PhD, Lionel Karlin, Brigitte Kolb, Mourad Tiab, MD, Carla Araujo, Nathalie Meuleman, Thierry De Revel, Pascal Bourquard, Pascal Lenain, MD, Murielle Roussel, MD, Arnaud Jaccard, MD PhD, Marie-Odile Petillon, Karim Belhadj-Merzoug, Gerard Lepeu, Marie-Lorraine Chretien, Jean Fontan, Philippe Rodon, MD, Anna Schmitt, Fritz Offner, Laurent Voillat, Sophie Cereja, Frederique Kuhnowski, Sophie Rigaudeau, Olivier Decaux, MD PhD, Catherine Humbrecht-Kraut, Jamile Frayfer, Olivier Fitoussi, Damien Roos Weil, Jean Claude Eisenmann, MD, Veronique Dorvaux, Eric G. Voog, MD, Cyrille Hulin, Michel Attal, Philippe Moreau, Thierry Facon, MD
Journal: Blood
Blood (2015) 126 (23): 3028.
https://doi.org/10.1182/blood.V126.23.3028.3028
Published: 2015
Journal Articles

Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial

Nizar J Bahlis, MD, Alessandro Corso, Lars-Olof Mugge, Zhi-Xiang Shen, Pierre Desjardins, Anne-Marie Stoppa, MD, Olivier Decaux, Thierry De Revel, Miquel Granell, Gerald Marit, Hareth Nahi, Hilde Demuynck, Shang-Yi Huang, Supratik Basu, Troy H. Guthrie, Annette Ervin-Haynes, Nicolas Leupin, Jennifer Marek, Guang Chen, Thierry Facon
Journal: Blood
Blood (2014) 124 (21): 3458.
https://doi.org/10.1182/blood.V124.21.3458.3458
Published: 2014
Journal Articles

Outcomes of Cord Blood Transplantation Using Reduced Intensity Conditioning for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of Eurocord, SFGM-TC and Cqwp-EBMT

Erick Xavier, MD, Jérôme Cornillon, MD, Annalisa Ruggeri, MD PhD, Patrice Chevallier, MD PhD, Jan J. Cornelissen, MD PhD, Niels S. Andersen, MD, Natacha Maillard, MD, Stephanie Nguyen-coq, MD, Didier Blaise, MD, Eric Deconinck, Hendrik Veelken, MDPhD, Anne Corby, MD, Anna Huynh, MD, Marta Sonia Gonzalez Perez, MD, Jean-Yves Cahn, MD PhD, Noel Milpied, MD PhD, Mohamad Mohty, MD PhD, Mauricette Michallet, MD PhD, Jean-Henri Bourhis, MD PhD, Thierry de Revel, Christian Berthou, Patrice Ceballos, MD, Pascal Turlure, MD, Irene Donnini, MD, Simona Sica, MD, Regis Peffault de la tour, MD PhD, Eliane Gluckman, MD, Nicolaus Kroeger, MD, Johannes Schetelig, MD M. Sc,, Vanderson Rocha, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2581.
https://doi.org/10.1182/blood.V124.21.2581.2581
Published: 2014
Journal Articles

Endogenous TGF-beta1 Mediated Osteogenic Impairment of Medullar Mesenchymal Stromal Cells in Primary Myelofibrosis

Christophe Martinaud, MD, Christophe Desterke, PhD, Johanna Konopacki, MD, Lisa Pieri, MDPhD, Rachel Golub, PhD, Sandrine Schmutz, PhD, Adrienne Anginot, PhD, Bernadette Guerton, Nathalie Rochet, MD PhD, Patricia Albanese, PhD, Emilie Henault, Thierry De Revel, Marie-Françoise Bourgeade, PhD, Vanucchi Alessandro, MD, Jean-Jacques Lataillade, MD PhD, Marie-Caroline Le Bousse-Kerdilès, PhD
Journal: Blood
Blood (2014) 124 (21): 1873.
https://doi.org/10.1182/blood.V124.21.1873.1873
Published: 2014
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for T-Prolymphocytic leukemia: A Retrospective Analysis From the Societe française De Greffe De Moelle Et De Therapie Cellulaire

Thierry Guillaume, MD, Yves Beguin, Véronique Leblond, Didier Blaise, MD, Noel Milpied, MD, Eric Deconinck, Catherine Cordonnier, Jerome Cornillon, Nathalie Contentin, Gaelle Guillerm, Nathalie Fegueux, MD, Pascal Turlure, MD, Alexandra Salmon, Thierry de Revel, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2012) 120 (21): 2008.
https://doi.org/10.1182/blood.V120.21.2008.2008
Published: 2012
Journal Articles

Prognostic Significance of DNA Methyltransferase 3A Mutations in Cytogenetically Normal Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association

Aline Renneville, Nicolas Boissel, Olivier Nibourel, Céline Berthon, MD, Nathalie Helevaut, Claude Gardin, MD, Jean-Michel Cayuela, Sandrine Hayette, MD, PhD, Oumedaly Reman, MD, Nathalie Contentin, Dominique Bordessoule, Cécile Pautas, Stephane de Botton, Thierry De Revel, MD, PhD, Christine Terre, Pierre Fenaux, MD, PhD, Xavier Thomas, MD, PhD, Sylvie Castaigne, Herve Dombret, Claude Preudhomme
Journal: Blood
Blood (2011) 118 (21): 2506.
https://doi.org/10.1182/blood.V118.21.2506.2506
Published: 2011
Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC),

Sophie Park, Myriam Labopin, MD, MS, Ibrahim Yakoub-Agha, MD, PhD, Jacques Delaunay, Nathalie Dhedin, Agnes Buzyn, MD, PhD, Eric Deconinck, MD, PhD, Mauricette Michallet, Marie Robin, Thierry De Revel, MD, PhD, Marc Bernard, Norbert Vey, MD, Bruno Lioure, Simona Lapusan, Anne Sirvent, Reza Tabrizi, MD, Jean-Henri Bourhis, Christian Recher, MD, PhD, Yves Beguin, MD, PhD, Pierre Fenaux, MD, PhD, Mohamad Mohty
Journal: Blood
Blood (2011) 118 (21): 3794.
https://doi.org/10.1182/blood.V118.21.3794.3794
Published: 2011
Journal Articles

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

Sylvie Castaigne, Cécile Pautas, Christine Terre, Emmanuel Raffoux, MD, PhD, Dominique Bordessoule, Jean-Noel Bastie, MD, PhD, Ollivier Legrand, Xavier Thomas, MD, PhD, Pascal Turlure, Oumedaly Reman, Thierry De Revel, Lauris Gastaud, Claude Gardin, MD, Laurent Sutton, Jean Pierre Marolleau, Stephane De Botton, Olivier Hermine, Isabelle Plantier, Maud Janvier, Brigitte Dupriez, Marc Simon, Noemie De Gunzburg, Stephanie Foucault-Haiat, Nathalie Contentin, Celine Berthon, Pierre Fenaux, MD, PhD, Estelle Henry, Philippe Rousselot, MD, PhD, Claude Preudhomme, Sylvie Chevret, Hervé Dombret
Journal: Blood
Blood (2011) 118 (21): 6.
https://doi.org/10.1182/blood.V118.21.6.6
Published: 2011
Journal Articles

Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study

Clinical Trials & Observations
Xavier Thomas, Mohamed Elhamri, Emmanuel Raffoux, Aline Renneville, Cécile Pautas, Stéphane de Botton, Thierry de Revel, Oumedaly Reman, Christine Terré, Claude Gardin, Youcef Chelghoum, Nicolas Boissel, Bruno Quesnel, Yosr Hicheri, Jean-Henri Bourhis, Pierre Fenaux, Claude Preudhomme, Mauricette Michallet, Sylvie Castaigne, Hervé Dombret
Journal: Blood
Blood (2011) 118 (7): 1754–1762.
https://doi.org/10.1182/blood-2011-04-349258
Published: 2011
Journal Articles

Allogeneic Stem Cell Transplantation for Blast Crisis (BC) Chronic Myelogenous Leukemia (CML) In the Tyrosine Kinase Inhibitors (TKIs) Era. Analysis of Pre-Transplant Variables on Transplant Outcome. On Behalf of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire and the French Group of CML

Franck Nicolini, MD, PhD, Laurent Modolo, Stat, Nicole Raus, Data, Noel Milpied, MD, Gerard Socie, MD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, Nathalie Fegueux, MD, Herve Tilly, MD, Didier Blaise, MD, Pierre Bordigoni, MD, Karin Bilger, MD, Catherine Cordonnier, Jean-Hugues Dalle, MD, PhD, Thierry De Revel, MD, PhD, Eric Deconninck, MD, Bernard Rio, MD, Anne Sirvent, Norbert Ifrah, MD, Gaelle Guillerm, MD, Valerie Mialou, Agnes Buzyn, MD, PhD, Anne Huynh, MD, Jacques-Olivier Bay, MD, PhD, Stephane Morisset, Stat., Mauricette Michallet
Journal: Blood
Blood (2010) 116 (21): 2266.
https://doi.org/10.1182/blood.V116.21.2266.2266
Published: 2010
Journal Articles

Long-Term Outcome Associated with Current Allogeneic Stem Cell Transplantation Procedures In Younger Adults with Adverse-Risk AML In First CR – A Real-Life Transplant Versus No-Transplant Analysis of the Acute Leukemia French Association (ALFA)

Marie-Anne Hospital, Xavier Thomas, Sylvie Castaigne, Emmanuel Raffoux, Sébastien Maury, Claude Gardin, Jean-Henri Bourhis, Oumedaly Reman, Stéphane de Botton, Thierry de Revel, Christine Terré, Claude Preudhomme, Cécile Pautas, Pierre Fenaux, MD, PhD, Mauricette Michallet, Gérard Socié, Hervé Dombret, M.D.
Journal: Blood
Blood (2010) 116 (21): 3513.
https://doi.org/10.1182/blood.V116.21.3513.3513
Published: 2010
Journal Articles

Efficacy and Safety of Rituximab in Common Variable Immunodeficiency-Associated Immune Cytopenias: a Retrospective Analysis of 10 Cases.

Delphine Gobert, Lionel Galicier, Alice Berezne, Christophe Auzary, Thierry de Revel, Felipe Suarez, MD, PhD, Bernard Bonnotte, Roland Jaussaud, Marc Ruivard, Bertrand Godeau, Olivier Hermine, Marc Michel
Journal: Blood
Blood (2009) 114 (22): 1310.
https://doi.org/10.1182/blood.V114.22.1310.1310
Published: 2009
Journal Articles

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Giovanna Cannas, MD, Anne Huynh, Stéphane Morisset, MSc, Mohamad Sobh, Pharm.M, Nicole Raus, Frederic Garban, MD, Catherine Cordonnier, MD, Jacques-Olivier Bay, Jérôme Cornillon, Agnes Buzyn, Ibrahim Yakoub-Agha, MD, PhD, Catherine Faucher, Sylvie Francois, Pierre Bordigoni, Pr, Nathalie Fegueux, MD, Loic Fouillard, Marie Robin, MD, Eric Deconinck, Oumédaly Reman, MD, Nathalie Dhedin, Thierry De Revel, MD, PhD, Bruno Lioure, MD, Noel Milpied, MD, PhD, Mohamad Mohty, MD, PhD, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4335.
https://doi.org/10.1182/blood.V114.22.4335.4335
Published: 2009
Journal Articles

Fatigue and Daily Life in Patients with Essential Thrombocythemia: Comparisons Between the USA and France in 447 Patients.

Ruben A. Mesa, MD, Jerome Rey, MD, Ayalew Tefferi, MD, Joyce Niblack, JD, Pascal Lenain, Emmanuel Raffoux, MD, Thierry De Revel, MD, PhD, John Camoriano, MD, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2904.
https://doi.org/10.1182/blood.V114.22.2904.2904
Published: 2009
Journal Articles

Long-Term Survival Analysis in Older Patients with AML Treated Intensively: Positive Impact of Idarubicin in a Cure Fraction Estimation Model.

Hervé Dombret, Claude Gardin, Sylvie Chevret, Cecile Pautas, Pascal Turlure, Xavier Thomas, Bruno Quesnel, Thierry de Revel, Christine Terré, Pierre Fenaux, Dominique Bordessoule, Sylvie Castaigne
Journal: Blood
Blood (2008) 112 (11): 960.
https://doi.org/10.1182/blood.V112.11.960.960
Published: 2008
Journal Articles

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

Xavier Thomas, Emmanuel Raffoux, Aline Renneville, Cécile Pautas, MD, Stephane de Botton, Thierry de Revel, Oumedaly Reman, Christine Terre, Claude Gardin, Quoc-Hung Le, Nathalie Philippe, Catherine Cordonnier, MD, Jean-Henri Bourhis, Mohamed Elhamri, Sandrine Hayette, Christine Parmentier, Pierre Fenaux, Sylvie Castaigne, MD, Claude Preudhomme, PhD, Hervé Dombret
Journal: Blood
Blood (2008) 112 (11): 765.
https://doi.org/10.1182/blood.V112.11.765.765
Published: 2008
Journal Articles

NOTCH1/FBXW7 Mutation Identifies a Large Subgroup with Favorable Outcome in Adult T-ALL: A GRAALL Study.

Vahid Asnafi, Agnes Buzyn, Sandrine Lenoir, Fréderic Baleydier, Arnauld Simon, Kheira Beldjord, Oumedaly Reman, Francis Witz, Thierry de Revel, Emmanuelle Tavernier, Pascal Turlure, Thibaut Leguay, Francoise Huguet, Jean- Paul Vernant, Veronique Lhéritier, Marie-Christine Béné, Norbert Ifrah, Xavier Thomas, Hervé Dombret, Elizabeth MacIntyre, PhD
Journal: Blood
Blood (2008) 112 (11): 1494.
https://doi.org/10.1182/blood.V112.11.1494.1494
Published: 2008
Journal Articles

Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study.

Cecile Pautas, Xavier Thomas, Fatiha Merabet, Emmanuel Raffoux, Jean Henri Bourhis, Stephane de Botton, Oumedaly Reman, Pascal Turlure, Claude Gardin, Nathalie Contentin, Thierry de Revel, Isabelle Plantier, Philippe Rousselot, Claude Preudhomme, Pierre Fenaux, Maud Janvier, Christine Terre, Herve Dombret, Mauricette Michallet, Sylvie Chevret, Sylvie Castaigne
Journal: Blood
Blood (2007) 110 (11): 162.
https://doi.org/10.1182/blood.V110.11.162.162
Published: 2007
Journal Articles

Decision Criteria for the Futility of Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML).

Hervé Dombret, Jean-Valère Malfuson, Anne Etienne, Pascal Turlure, Thierry de Revel, Xavier Thomas, Nathalie Contentin, Christine Terré, Mauricette Michallet, Sylvie Castaigne, Dominique Bordessoule, Norbert Vey, Claude Gardin
Journal: Blood
Blood (2007) 110 (11): 2861.
https://doi.org/10.1182/blood.V110.11.2861.2861
Published: 2007